๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: improved efficacy with higher dosing

โœ Scribed by Thomas C Abshire


Book ID
117821761
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
139 KB
Volume
41
Category
Article
ISSN
1532-8686

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A multicentre, randomized, double-blind,
โœ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre